These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 28341836

  • 21. Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma.
    Zhang H, Jiang Y, Ni X, Chen L, Wu M, Liu J, Yang B, Shan X, Yang L, Fan J, Chen Y, Wu J, Fu S.
    J Biomed Nanotechnol; 2018 Jan 01; 14(1):114-126. PubMed ID: 29463369
    [Abstract] [Full Text] [Related]

  • 22. Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
    Du HF, Yu LJ, Meng YF, Lv HY, Meng J, Song XN, Zhang JQ.
    Leuk Lymphoma; 2013 Mar 01; 54(3):607-18. PubMed ID: 22889356
    [Abstract] [Full Text] [Related]

  • 23. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
    Jiang S, Li M, Hu Y, Zhang Z, Lv H.
    Carbohydr Polym; 2018 Oct 01; 197():194-203. PubMed ID: 30007605
    [Abstract] [Full Text] [Related]

  • 24. Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells.
    Qiu P, Wang S, Liu M, Ma H, Zeng X, Zhang M, Xu L, Cui Y, Xu H, Tang Y, He Y, Zhang L.
    BMC Cancer; 2017 Jan 13; 17(1):55. PubMed ID: 28086832
    [Abstract] [Full Text] [Related]

  • 25. Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells.
    Huang S, Tuergong G, Zhu H, Wang X, Weng G, Ren Y.
    Acta Pharm; 2021 Jun 01; 71(2):267-278. PubMed ID: 33151174
    [Abstract] [Full Text] [Related]

  • 26. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
    Guan M, Zhou Y, Zhu QL, Liu Y, Bei YY, Zhang XN, Zhang Q.
    Nanomedicine; 2012 Oct 01; 8(7):1172-81. PubMed ID: 22321383
    [Abstract] [Full Text] [Related]

  • 27. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
    Jiang Z, Chi J, Han B, Liu W.
    Carbohydr Polym; 2017 Oct 15; 174():282-290. PubMed ID: 28821069
    [Abstract] [Full Text] [Related]

  • 28. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
    Xie D, Xie J, Wan Y, Ma L, Qi X, Wang K, Yang S.
    Oncol Rep; 2016 Apr 15; 35(4):2191-7. PubMed ID: 26781164
    [Abstract] [Full Text] [Related]

  • 29. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
    Liu Y, Zahng J, You Z, Liao H.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug 15; 30(8):824-8. PubMed ID: 25108435
    [Abstract] [Full Text] [Related]

  • 30. Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells.
    Ye Y, Song Y, Zhuang J, Wang G, Ni J, Xia W.
    J Cell Physiol; 2019 Feb 15; 234(2):1880-1888. PubMed ID: 30067868
    [Abstract] [Full Text] [Related]

  • 31. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.
    Ma L, He H, Jiang K, Jiang P, He H, Feng S, Chen K, Shao J, Deng G.
    Aging (Albany NY); 2020 Apr 13; 12(7):6352-6369. PubMed ID: 32283544
    [Abstract] [Full Text] [Related]

  • 32. Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway.
    Chen AW, Tseng YS, Lin CC, Hsi YT, Lo YS, Chuang YC, Lin SH, Yu CY, Hsieh MJ, Chen MK.
    Environ Toxicol; 2018 Mar 13; 33(3):343-350. PubMed ID: 29193574
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological mechanisms of norcantharidin against hepatocellular carcinoma.
    Qian ZM, Chen YJ, Bao YX.
    Am J Cancer Res; 2023 Mar 13; 13(11):5024-5038. PubMed ID: 38058814
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I, Pinyol R, Dauch D, Torrecilla S, Tovar V, Moeini A, Alsinet C, Portela A, Rodriguez-Carunchio L, Solé M, Lujambio A, Villanueva A, Thung S, Esteller M, Zender L, Llovet JM.
    Gastroenterology; 2016 Dec 13; 151(6):1192-1205. PubMed ID: 27614046
    [Abstract] [Full Text] [Related]

  • 38. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
    Zhang M, Li Q, Zhang L, Wang Y, Wang L, Li Q, He T, Wan B, Wang X.
    Cell Mol Biol (Noisy-le-grand); 2018 Apr 30; 64(5):73-79. PubMed ID: 29729697
    [Abstract] [Full Text] [Related]

  • 39. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.
    Xie J, Zhang Y, Hu X, Lv R, Xiao D, Jiang L, Bao Q.
    Med Oncol; 2015 May 30; 32(5):145. PubMed ID: 25814287
    [Abstract] [Full Text] [Related]

  • 40. [Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells].
    Li GQ, Zhang SJ, Lü JF, Wu Y, Li J, Zhang G, Yu JT.
    Zhonghua Yi Xue Za Zhi; 2010 Aug 10; 90(30):2145-8. PubMed ID: 21029633
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.